期刊文献+

NYD-SP15基因的原核表达及多克隆抗体的制备 被引量:3

Prokaryotic expression plasmid of NYD-SP15 and preparation of polyclonal antibody
下载PDF
导出
摘要 目的:克隆NYD-SP15基因,构建融合表达载体,在大肠杆菌中表达,并制备抗体。方法:PCR技术扩增NYD-SP15全长开放阅读框,克隆入原核表达载体PET28a,转化大肠杆菌感受态细胞,异丙基硫代-β-D-半乳糖苷(IPTG)诱导后收集菌体蛋白,行SDS-PAGE电泳。将此融合蛋白Ni柱纯化后免疫BALB/C小鼠,Western blotting鉴定。结果:成功地构建了PET28a-NYD-SP15原核表达质粒,并获得了高效表达NYD-SP15的BL21菌株,表达的His标签融合蛋白,分子量为58kDa左右,经免疫小鼠获得了抗NYD-SP15抗体。经Western blotting法分析,抗体为NYD-SP15特异性抗体。结论:构建的NYD-SP15基因的原核表达载体,体外高效表达蛋白,免疫小鼠获得抗NYD-SP15抗体,将为眼部增殖性视网膜病变(PVR)的研究及治疗奠定坚实的基础。 AIM : To construct the prokaryotic expression plasmid of NYD-SP15 which is related to proliferative lesion, induce protein expression in vitro and immunize mouse for antibody. METHODS: Open-reading frame of NYD-SP15 gene was amplified by PCR technique, then we inserted it into PET28a prokaryotic expression vector and transformed into expressing strain. Its protein expression was induced by isoproprlthiogalactoside (IPTG), then purified by Ni stele. Eight- week-old BALB/C mice were immunized by the purified protein to obtain antibody. The protein and its antibody were checked by Western blotting technique. RESULTS: We had successfully constructed NYD-SP15' prokaryotic plasmid, and the BL21 strain that highly expressed NYD-SP15 protein. The molecular weight of this His tagged-fusion protein was about 58 kDa. Polyclonal antibody was gained from immune mouse and the specificity was determined by Western blotting. CONCLUSION : NYD-SP15 prokaryotic expression vector, the highly expression protein in vitro and its polyclonal antibody may establish a substantial foundation for the research and treatment of the proliferative retinopathy.
出处 《国际眼科杂志》 CAS 2008年第3期483-486,共4页 International Eye Science
基金 中国国家自然科学基金资助项目(No.30000088)~~
关键词 原核表达 NYD—SP15 多克隆抗体 prokaryotic expression NYD-SP15 polyclonal antibody
  • 相关文献

参考文献5

二级参考文献24

  • 1项奕,曾水清.The Anti-Proliferative Effect of Inhibitor of Telomerase on Cultured Retinal Pigment Epithelial Cells[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2001,21(2):174-176. 被引量:4
  • 2张喜梅,张皙,王方,富名水,顾青.增生性玻璃体视网膜病变患者血清和眼内液HGF水平检测[J].眼科研究,2003,21(6):645-647. 被引量:5
  • 3焦剑,刘武,莫宾,杨琳.应用激光房水细胞仪定量研究PVR模型中PDTC对房水闪光的抑制作用(英文)[J].国际眼科杂志,2005,5(1):23-30. 被引量:2
  • 4康军,崔志利,海鸥,安洁,高丹宇.细胞因子及苏拉明对视网膜色素上皮细胞增殖的影响[J].国际眼科杂志,2005,5(4):655-658. 被引量:9
  • 5Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J.Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy. Am J Ophthalmol,2000; 129 (5):678 -680
  • 6Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S,Graziani A, Panayotou G, Comoglio PM. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell,1994;77:261-271
  • 7Machemer R, Van Horn D, Aberg TM. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol, 1978;85:181-191
  • 8Casaroli-Marano RP, Pagan R, Vilaro S. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci,1999;40(9):2062-2072
  • 9Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N.Vascular Endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.Am J Pathol,2000;156:1337-1344
  • 10Kon CH,Oeeleston N L,Charteris D,Daniels J.Aylward GW,Khaw PT.A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.Invest Ophthalmol Vis Sci,1998;39:1524-1529

共引文献20

同被引文献22

  • 1Carrington L, Mcleod D, Bouhon M. IL-10 and antibodies to TGF-β2 and PDGF inhibit RPE mediated retinal contraction.Invest Ophthalmol Vis Sci 2000;41(5) :1210-1216
  • 2Retaux S, Bachy I. A short history of LIM domains (1993-2002) : from protein interaction to degradation. Mol Neurobiol 2002 ; 26 ( 2-3 ) : 269-281
  • 3Retaux S, Bachy I. A short history of LIM domains (1993-2002) : from protein interaetion to degradation. Mol Neurobiol 2002 ; 26 ( 2-3 ) : 269-281
  • 4Kadrmas JL, Beckerle MC, The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 2004:5( 11 ) :920-931
  • 5Charttris DG. Proliferative vitreoretinopathy: pathobiology, surgical management and adjunctive treatment. Br J Ophthalmol 1995 ; 79 ( 10 ) : 953 -960
  • 6Kania A, Johnson RL, Jessell TM. Coordinate roles for LIM homeobox genes in directing the dorsoventral trajectory of motor axons in the vertebrate limb. Cell 2000 ; 102 ( 2 ) : 161 -173
  • 7Varela-Echavarria A, Pfaff SL, Guthrie S. Differential expression of LIM homeobox genes among motor neuron subpopulations in tile developing chick hrain stein. Mol Cell Neurosci 1996 ; 8 ( 4 ) : 242-257
  • 8Chen Y, Lai M, Maeno-Hikichi Y, et al. Essential role of the LIM domain in the formation of the PKCepsilon-ENH-N-typc Ca^2+ channel complex. Cell Signal 2006 ; 18 ( 2 ) : 215-224
  • 9Grutz G, Forster A, Rabbitts TH. Identification of the LMO4 gene encoding an interaction partner of tile LIM-binding protein LDB1 /NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia. Oncogene 1998 ; 17 ( 21 ) : 2799-2803
  • 10Sharma K, Sheng HZ, Lettieri K, et al. LIM homeodomain factors Lhx3 and Lhx4 assign subtype ideniities for motor neurons. Cell 1998 ;95 (6) :817-828

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部